You have 9 free searches left this month | for more free features.

City

Austin (1)

Boston (1)

Houston (1)

Philadelphia (1)

San Antonio (1)

Condition

Colorectal Cancer (2)

Advanced Solid Tumor (1)

GIST (1)

Melanoma (1)

Metastatic Solid Tumor (1)

Non-Small Cell Lung Cancer (1)

Pancreatic Ductal Adenocarcinoma (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

Deciphera Pharmaceuticals LLC (2)

Collaborator

Pfizer (1)

Intervention

dcc-3116 (2)

binimetinib (1)

cetuximab (1)

encorafenib (1)

ripretinib (1)

sotorasib (1)

trametinib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

dcc-3116

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Colorectal Cancer, GIST Trial (DCC-3116, Ripretinib, Cetuximab)

Not yet recruiting

Colorectal Cancer
GIST

DCC-3116
+3 more

(no location specified)

Jul 14, 2023

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)

Recruiting

Pancreatic Ductal Adenocarcinoma
+5 more

DCC-3116
+3 more

Boston, Massachusetts
+4 more

May 25, 2022